BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 32271437)

  • 1. Overexpression of XIST facilitates cell proliferation, invasion and suppresses cell apoptosis by reducing radio-sensitivity of glioma cells via miR-329-3p/CREB1 axis.
    Wang YP; Li HQ; Chen JX; Kong FG; Mo ZH; Wang JZ; Huang KM; Li XN; Yan Y
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3190-3203. PubMed ID: 32271437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA XIST confers aggressive progression via miR-361-3p/STX17 in retinoblastoma cells.
    Yang LL; Li Q; Zhang X; Cao T
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10433-10444. PubMed ID: 33155266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
    Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
    Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis.
    Liu X; Xie S; Zhang J; Kang Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528
    [No Abstract]   [Full Text] [Related]  

  • 6. Knockdown of lncRNA XIST inhibits hypoxia-induced glycolysis, migration and invasion through regulating miR-381-3p/NEK5 axis in nasopharyngeal carcinoma.
    Zhao CH; Bai XF; Hu XH
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2505-2517. PubMed ID: 32196601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA XIST knockdown suppresses the growth of colorectal cancer cells via regulating microRNA-338-3p/PAX5 axis.
    Li W; He Y; Cheng Z
    Eur J Cancer Prev; 2021 Mar; 30(2):132-142. PubMed ID: 32826710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LINC00346 regulates proliferation and apoptosis by targeting miR-128-3p/SZRD1 axis in glioma.
    Geng YB; Pan CC; Xu C; Zuo PC; Wang Y; Li XO; Zhang LW
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9581-9590. PubMed ID: 33015801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MiR-26-3p regulates proliferation, migration, invasion and apoptosis of glioma cells by targeting CREB1].
    Huang Q; Zhou J; Wang Z; Yang K; Chen Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):578-584. PubMed ID: 38597450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of SNHG15 facilitates cell proliferation, migration, invasion and suppresses cell apoptosis in breast cancer by regulating miR-411-5p/VASP axis.
    Liu LB; Jiang ZJ; Jiang XL; Wang S
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1899-1912. PubMed ID: 32141559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of lncRNA XIST suppresses proliferation and autophagy and enhances vincristine sensitivity in retinoblastoma cells by sponging miR-204-5p.
    Yao L; Yang L; Song H; Liu TG; Yan H
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3526-3537. PubMed ID: 32329826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
    Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA NEAT1 promotes human glioma tumor progression via miR-152-3p/CCT6A pathway.
    Li B; Lu X; Ma C; Sun S; Shu X; Wang Z; Sun W
    Neurosci Lett; 2020 Jul; 732():135086. PubMed ID: 32454145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA X-inactive specific transcript suppresses the progression of hepatocellular carcinoma through microRNA-221-3p-targeted regulation of O6-methylguanine-DNA methyltransferase.
    Chen Z; Qi L; Fu H; Ma L
    Bioengineered; 2022 May; 13(5):14013-14027. PubMed ID: 35723009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis.
    Dong Z; Liu H; Zhao G
    Cancer Biother Radiopharm; 2020 Jun; 35(5):351-361. PubMed ID: 32202941
    [No Abstract]   [Full Text] [Related]  

  • 19. GINS2 was regulated by lncRNA XIST/miR-23a-3p to mediate proliferation and apoptosis in A375 cells.
    Hao YQ; Liu KW; Zhang X; Kang SX; Zhang K; Han W; Li L; Li ZH
    Mol Cell Biochem; 2021 Mar; 476(3):1455-1465. PubMed ID: 33389496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA XIST regulates myocardial infarction by targeting miR-130a-3p.
    Zhou T; Qin G; Yang L; Xiang D; Li S
    J Cell Physiol; 2019 Jun; 234(6):8659-8667. PubMed ID: 29226319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.